We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Scalable Protocol to Differentiate Skeletal Muscle Cells from Stem Cells
Product News

Scalable Protocol to Differentiate Skeletal Muscle Cells from Stem Cells

Scalable Protocol to Differentiate Skeletal Muscle Cells from Stem Cells
Product News

Scalable Protocol to Differentiate Skeletal Muscle Cells from Stem Cells


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Scalable Protocol to Differentiate Skeletal Muscle Cells from Stem Cells"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

amsbiopr163-image.jpg

The new kit utilizes a highly efficient media based protocol to produce skeletal muscle cells from stem cells in a simple, scalable manner.

The potential to differentiate stem cells into specific cell types is revolutionizing life sciences, from new methods of studying developmental biology and novel approaches to producing accurate disease models to techniques to help drug discovery and toxicity testing.

Until recently methods of studying muscular disease and potential therapies were dependent on invasive muscle biopsies to produce limited batches of primary cells. Use of primary cells presents challenges, not only in the collection process but also related to inconsistencies in cell growth, behavior and life span, making it difficult to generate reliable experimental models. 

The new Skeletal Muscle Differentiation kit offers researchers a unique tool to rapidly differentiate donor stems into functional myotubes in a reproducible fashion. Tested on a wide range of human embryonic and induced pluripotent stem cell lines the new kit follows a simple 3-step process of media changes and cell passaging. Eliminating the need for cell sorting or transfection of myogenic transcription factors, the three step protocol generates a highly pure population of approximately 70 per cent skeletal muscle myotubes in weeks.

Advertisement